Vulvar Paget's disease: a population-based cancer registry descriptive study. - 01/09/24
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
ABSTRACT |
Background |
: Although vulvar Paget's Disease (VPD) is a rare skin cancer associated with an excellent prognosis, high recurrence rates are associated with impaired quality of life.
Objectives |
: Our objective was to investigate the epidemiological and clinical features of VPD diagnosed in a French administrative area (Franche Comté).
Methods |
: This retrospective study investigated clinical, histologic, therapeutic and follow-up data of patients with VPD diagnosed between 1981 and 2021, including data from the Doubs cancer registry.
Results |
: Among the 21 patients included (19 intra-epithelial and 2 invasive VPD), the median time to diagnosis was 24 months [0-110 months], with a median age of 72 years [38-88 years]. An associated cancer was present in 6 patients (29%). At 5 years of follow-up, the recurrence rate was 26%, but then increased to 42% after a median follow-up of 145 months [31-503 months]. Among the 14 patients first surgically treated, incomplete resection (positive margins) was observed in all patients (100%), associated with a postoperative recurrence rate of 86% which was much higher than the rate observed in patients first topically treated (20%). Postoperative adjuvant therapy (surgical revision, laser, imiquimod) significantly increased the recurrence-free survival (p < 0.001).
Conclusions |
: Postoperative recurrence of VPD is frequent, mainly after 5 years, proving the importance of prolonged follow-up. Recurrence-free survival was significantly higher after postoperative adjuvant treatment.
Le texte complet de cet article est disponible en PDF.Keywords : vulvar Paget's disease, vulva, recurrence, surgery, topical, imiquimod
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?